The US Oncology Drugs Market represents a major share of the global oncology industry, driven by extensive cancer research activities, strong pharmaceutical innovation, and high adoption of advanced treatment modalities. The country benefits from a large pipeline of investigational oncology drugs, robust clinical trial infrastructure, and significant investments in precision medicine and...